BTKI

Clinical trials for BTKI explained in plain language.

Never miss a new study

Get alerted when new BTKI trials appear

Sign up with your email to follow new studies for BTKI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for aggressive lymphoma: drug cocktail aims to control High-Risk MCL

Disease control Recruiting now

This phase 2 trial is testing whether adding the drug glofitamab after an initial treatment with acalabrutinib (or zanubrutinib) and rituximab can better control high-risk mantle cell lymphoma (MCL) in people who have not been treated before. The study will enroll 30 participants…

Matched conditions: BTKI

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 23, 2026 11:57 UTC

BTKI

Get alerted when new BTKI trials appear

New hope for aggressive lymphoma: drug cocktail aims to control High-Risk MCL